Snehal Patel - 24 Dec 2024 Form 4 Insider Report for Greenwich LifeSciences, Inc. (GLSI)

Role
CEO and CFO, Director, 10%+ Owner
Signature
/s/ Snehal Patel
Issuer symbol
GLSI
Transactions as of
24 Dec 2024
Net transactions value
$0
Form type
4
Filing time
27 Dec 2024, 16:19:45 UTC
Previous filing
30 Sep 2024
Next filing
02 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GLSI Stock Options Award $0 +1,148,723 +107% $0.000000 2,222,454 24 Dec 2024 Common Stock 1,148,723 $12.16 Direct F1
transaction GLSI Stock Options Award $0 +25,008 +1.1% $0.000000 2,247,462 24 Dec 2024 Common Stock 25,008 $12.16 By Wife F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 262,181 options are earned upon date of grant and 786,542 options are earned monthly over 36 months. 10% of the earned options vest if reporting person has been employed by Issuer between 1-2 years from grant date, 20% of the earned options vest if reporting person has been employed by Issuer between 2-3 years from grant date, 30% of the earned options vest if reporting person has been employed by Issuer between 3-4 years from grant date and the remaining earned options vest if reporting person has been employed by Issuer more than 4 years after grant date. 100,000 options are earned and vest upon date of grant.
F2 6,252 options are earned and vest upon date of grant and the remainder are earned and vest monthly over 36 months.